HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enda W McDermott Selected Research

Circulating Neoplastic Cells

5/2018Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA.
1/2015Biomarkers in Breast Cancer: Where Are We and Where Are We Going?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Enda W McDermott Research Topics

Disease

15Breast Neoplasms (Breast Cancer)
01/2022 - 04/2003
10Neoplasms (Cancer)
01/2017 - 01/2004
3Melanoma (Melanoma, Malignant)
01/2017 - 08/2012
2Circulating Neoplastic Cells
05/2018 - 01/2015
2Neoplasm Metastasis (Metastasis)
10/2010 - 07/2005
2Lymphatic Metastasis
10/2010 - 07/2005
1Neoplasm Micrometastasis
07/2021
1Wounds and Injuries (Trauma)
01/2021
1Sarcoma (Soft Tissue Sarcoma)
01/2021
1Margins of Excision
01/2020
1Paraganglioma (Paragangliomas)
01/2013
1Pheochromocytoma
01/2013
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2013
1Rare Diseases (Rare Disease)
01/2013
1Breast Diseases (Breast Disease)
10/2010
1Ductal Carcinoma
01/2008
1Fibroadenoma
07/2005
1Neutropenic Enterocolitis
06/2003

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
05/2018 - 01/2004
6Biomarkers (Surrogate Marker)IBA
05/2018 - 09/2006
3Hormones (Hormone)IBA
01/2022 - 07/2005
3DNA (Deoxyribonucleic Acid)IBA
01/2015 - 03/2005
3Estrogen ReceptorsIBA
01/2015 - 01/2004
2Trastuzumab (Herceptin)FDA Link
01/2018 - 01/2015
2Messenger RNA (mRNA)IBA
06/2011 - 07/2005
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
01/2022
1ProgesteroneFDA LinkGeneric
01/2022
1Clomiphene (Clomifene)FDA LinkGeneric
01/2022
1GonadotropinsIBA
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2021
1Circulating Tumor DNAIBA
05/2018
1iso-sulfan blue (Lymphazurin)FDA LinkGeneric
08/2015
1Coloring Agents (Dyes)IBA
08/2015
1IsotopesIBA
08/2015
1Complement System Proteins (Complement)IBA
06/2015
1NucleotidesIBA
06/2015
1Lapatinib (GW572016)FDA Link
01/2015
1Ado-Trastuzumab EmtansineIBA
01/2015
1pertuzumabIBA
01/2015
1CatecholaminesIBA
01/2013
1Polysaccharides (Glycans)IBA
10/2010
1Sialyl Lewis X AntigenIBA
10/2010
1Glycoside Hydrolases (Endoglycosidases)IBA
10/2010
1EpitopesIBA
10/2010
1Proto-Oncogene Proteins c-etsIBA
03/2005
1Mitogen-Activated Protein KinasesIBA
03/2005
1Transcription Factors (Transcription Factor)IBA
03/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2005
1Co-Repressor ProteinsIBA
03/2005
1RetinoidsIBA
01/2004
1Estradiol (Delestrogen)FDA LinkGeneric
01/2004
1Estrogens (Estrogen)FDA Link
01/2004
1afimoxifene (hydroxytamoxifen)IBA
01/2004
1Steroid Receptors (Steroid Receptor)IBA
01/2004
14,17 beta-dihydroxy-4-androstene-3-oneIBA
01/2004
1TamoxifenFDA LinkGeneric
01/2004

Therapy/Procedure

7Therapeutics
01/2021 - 01/2013
2Drug Therapy (Chemotherapy)
07/2021 - 09/2006
2Segmental Mastectomy (Lumpectomy)
01/2020 - 01/2008
2Adjuvant Chemotherapy
01/2017 - 01/2015
2Conservative Treatment
06/2006 - 06/2003
1Neoadjuvant Therapy
07/2021
1Mammaplasty (Breast Reconstruction)
01/2021
1Mastectomy (Mammectomy)
01/2021
1Radiotherapy
01/2013
1Lymph Node Excision (Lymph Node Dissection)
04/2003